0

Torcetrapib

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP262352170
CAS262352-17-0
Structure
MDL NumberMFCD09260777
Molecular Weight600.47
InChI KeyCMSGWTNRGKRWGS-NQIIRXRSSA-N
Description≥98% (HPLC)
SolubilityDMSO: >5 mg/mL
Assay≥98% (HPLC)
Colorwhite
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week

Jane Armitage, Michael V Holmes, David Preiss

J Am Coll Cardiol. 2019 Feb 5;73(4):477-487.

PMID: 30704580

1

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J Barter, Mark Caulfield, Mats Eriksson, Scott M Grundy, John J P Kastelein, Michel Komajda, Jose Lopez-Sendon, Lori Mosca, Jean-Claude Tardif, David D Waters, Charles L Shear, James H Revkin, Kevin A Buhr, etc.

N Engl J Med. 2007 Nov 22;357(21):2109-22.

PMID: 17984165

1

Gateways to Clinical Trials

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):159-84.

PMID: 12087878

1

Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib

Stephen A Williams, Ashwin C Murthy, Robert K DeLisle, Craig Hyde, Anders Malarstig, Rachel Ostroff, Sophie J Weiss, Mark R Segal, Peter Ganz

Circulation. 2018 Mar 6;137(10):999-1010.

PMID: 28974520

1

Trials and Tribulations of CETP Inhibitors

Alan R Tall, Daniel J Rader

Circ Res. 2018 Jan 5;122(1):106-112.

PMID: 29018035

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode